Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards
Robert D. Siegel(OSF Saint Francis Medical Center), MiKaela Olsen(Oncology Nursing Society), David W. Dougherty(Penn Center for AIDS Research), Elaine Stenstrup(City Of Hope National Medical Center), Therese M. Mulvey(Sidney Kimmel Cancer Center), Michael C Ganio(American Society of Health-System Pharmacists), Tamara P. Miller(Emory University), Meredith Klein(American Society of Clinical Oncology), Susan Tsai(The Ohio State University Wexner Medical Center), Amy Evers(University of Pennsylvania Health System), Maritza Salazar-Abshire(The University of Texas MD Anderson Cancer Center), Alexandre Chan(University of California, Irvine), Bradley D. Hunter(Intermountain Healthcare), Martha Polovich(University of Maryland, Baltimore), Sarah Temin(Virginia Cancer Institute), Kristine B. LeFebvre(Oncology Nursing Society), Amanda Ouzts(Huntsville Hospital), Lisa Barbarotta(Yale University), Christine Marie Sydenstricker, Ronda Bowman(American Society of Clinical Oncology)
Cited by 18
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JAMA Oncology|2015|1k
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2009|913
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
|Journal of Clinical Oncology|2015|903
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
|Journal of Clinical Oncology|2016|654